Southern Research provides bionanalytical research services for the comprehensive evaluation of drug candidates supporting both preclinical GLP and non-GLP studies. Bioanalytical research services are conducted in more than 10,000 square feet of custom-designed, dedicated pharmacy and laboratory space. These facilities house state-of-the-art instrumentation and automation, including LC/MS, LC/MS/MS, GC, GC/MS, and qPCR analytical platforms.
The extensive scientific expertise and industry experience of the Southern Research staff is applied to conducting method development/validation and bioanalysis of biological samples in addition to analytical analysis of dose formulations generated internally or from external laboratories. These samples can be derived from a wide range of preclinical activities, including but not limited to the following: ADME studies, PK/PD and toxicology evaluations, metabolic evaluations, biodistribution, and stability studies. We also support all types of clinical studies from ascending single- and multiple-dose studies to multi-site and bioequivalence.
Bioanalytical research services and capabilities include:
For more information about our capabilities, contact us at:
BusDev@SouthernResearch.org
888-322-1166 (U.S.)
1-205-581-2830 (International)